首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 11期“中国肝移植的发展与创新” => 肝脏肿瘤 =>LONP1基因在肝细..
LONP1基因在肝细胞癌中的表达及意义
Expression and significance of the LONP1 gene in hepatocellular carcinoma
文章发布日期:2019年09月29日  来源:  作者:张岩, 向晓星, 王翠梅  点击次数:192次  下载次数:36次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】: 目的 探讨LONP1基因在肝细胞癌(HCC)组织中的表达情况及临床意义。方法 选取由上海芯超生物有限公司提供的在2010年1月-2011年9月病理确诊为HCC的患者90例,根据LONP1蛋白在HCC癌组织中阳性表达程度,分为弱阳性组(n=33)、阳性组(n=24)、强阳性组(n=33)。用免疫组化的方法检测LONP1在癌及癌旁组织中的表达情况,并分析与HCC临床病理特征的关系。计数资料组间比较采用χ2检验或Fisher确切概率法。生存分析采用Kaplan-Meier方法及log-rank检验,影响因素分析采用Cox比例风险回归模型。结果 LONP1蛋白在HCC癌组织中的阳性表达率显著高于癌旁组织(100% vs 8.9%, χ2=152.308,P<0.001)。LONP1蛋白的表达与肿瘤有无包膜、有无合并肝硬化、临床分期和病理分级有关(P值均<0.05)。弱阳性组中位生存期40.545个月,阳性组28.545个月,强阳性组19.428个月,差异有统计学意义(χ2=32.058, P<0.001)。HCC患者的中位生存期与患者的LONP1蛋白表达强度、病理分级及临床分期有关(P值均<0.05)。多因素Cox分析结果显示以LONP1蛋白表达弱阳性为参照,LONP1蛋白阳性(风险比=0.109,95%可信区间:0.034~0.349,P<0.001)和强阳性(风险比=0.448,95%可信区间:0.219~0.918,P=0.028)是HCC患者生存的独立影响因素。结论 LONP1在HCC癌组织中表达水平较癌旁组织明显升高,且高表达患者的生存期较低表达者明显缩短。
【Abstract】: Objective To investigate the expression and clinical significance of the LONP1 gene in hepatocellular carcinoma (HCC). Methods A total of 90 patients with pathologically confirmed HCC from January 2010 to September 2011 were enrolled, and the microarrays for their HCC tissue and adjacent tissue samples were provided by Shanghai Xinchao Biological Co., Ltd. According to the level of positive expression of LONP1 in HCC tissue, the patients were divided into weak positive group with 33 patients, positive group with 24 patients, and strong positive group with 33 patients. Immunohistochemistry was used to measure the expression of LONP1 in HCC and adjacent tissue samples, and its association with the clinicopathological features of HCC was analyzed. The chi-square test or the Fisher’s exact test was used for comparison of categorical data between groups. The Kaplan-Meier method and the log-rank test were used for survival analysis, and the Cox proportional-hazards regression model was used to investigate risk factors. Results The positive expression rate of LONP1 protein in HCC tissue was significantly higher than that in the adjacent tissue (100% vs 8.9%, χ2=152.308, P<0.001). The expression of LONP1 protein was associated with presence or absence of tumor capsule, presence or absence of liver cirrhosis, clinical stage, and pathological grade (all P<0.05). There was a significant difference in median survival time between the weak positive group, the positive group, and the strong positive group (40.545 months vs 28.545 months vs 19.428 months, χ2=32.058, P<0.001). In HCC patients, median survival time was correlated with the expression of LONP1 protein, pathological grade, and clinical stage (all P<0.05). The multivariate Cox analysis showed that with the weak positive expression of LONP1 protein as a reference, positive expression of LONP1 protein (hazard ratio [HR]=0.109, 95% confidence interval [CI]: 0.034-0.349, P<0.001) and strong positive expression of LONP1 protein (HR=0.448, 95%CI: 0.219-0.918, P=0.028) were independent influencing factors for the survival of HCC patients. Conclusion The expression level of LONP1 in HCC tissue is significantly higher than that in adjacent tissue, and the patients with high expression of LONP1 have a significantly shorter survival time than those with low expression.
【关键字】:癌, 肝细胞; LONP1; 预后
【Key words】:carcinoma, hepatocellular; LONP1; prognosis
【引证本文】:ZHANG Y, XIANG XX, WANG CM. Expression and significance of the LONP1 gene in hepatocellular carcinoma[J]. J Clin Hepatol, 2019, 35(11): 2513-2516. (in Chinese)
张岩, 向晓星, 王翠梅. LONP1基因在肝细胞癌中的表达及意义[J]. 临床肝胆病杂志, 2019, 35(11): 2513-2516.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号